keyword
https://read.qxmd.com/read/38632257/amygdalar-neurotransmission-alterations-in-the-btbr-mice-model-of-idiopathic-autism
#1
JOURNAL ARTICLE
Maria Bove, Maria Adelaide Palmieri, Martina Santoro, Lisa Pia Agosti, Silvana Gaetani, Adele Romano, Stefania Dimonte, Giuseppe Costantino, Vladyslav Sikora, Paolo Tucci, Stefania Schiavone, Maria Grazia Morgese, Luigia Trabace
Autism Spectrum Disorders (ASD) are principally diagnosed by three core behavioural symptoms, such as stereotyped repertoire, communication impairments and social dysfunctions. This complex pathology has been linked to abnormalities of corticostriatal and limbic circuits. Despite experimental efforts in elucidating the molecular mechanisms behind these abnormalities, a clear etiopathogenic hypothesis is still lacking. To this aim, preclinical studies can be really helpful to longitudinally study behavioural alterations resembling human symptoms and to investigate the underlying neurobiological correlates...
April 17, 2024: Translational Psychiatry
https://read.qxmd.com/read/38629703/understanding-the-therapeutic-action-of-antipsychotics-from-molecular-to-cellular-targets-with-focus-on-the-islands-of-calleja
#2
JOURNAL ARTICLE
Merve Direktor, Peter Gass, Dragos Inta
The understanding of the pathophysiology of schizophrenia as well as the mechanisms of action of antipsychotic drugs remains a challenge for psychiatry. The demonstration of the therapeutic efficacy of several new atypical drugs targeting multiple different receptors apart from the classical dopamine D2 receptor as initially postulated unique antipsychotic target, complicated even more conceptualization efforts. Here we discuss results suggesting a main role of the islands of Calleja, still poorly studied GABAergic granule cell clusters in the ventral striatum, as cellular targets of several innovative atypical antipsychotics (clozapine, cariprazine and xanomeline/emraclidine) effective in treating also negative symptoms of schizophrenia...
April 17, 2024: International Journal of Neuropsychopharmacology
https://read.qxmd.com/read/38612739/is-there-a-place-for-lewy-bodies-before-and-beyond-alpha-synuclein-accumulation-provocative-issues-in-need-of-solid-explanations
#3
REVIEW
Paola Lenzi, Gloria Lazzeri, Michela Ferrucci, Marco Scotto, Alessandro Frati, Stefano Puglisi-Allegra, Carla Letizia Busceti, Francesco Fornai
In the last two decades, alpha-synuclein (alpha-syn) assumed a prominent role as a major component and seeding structure of Lewy bodies (LBs). This concept is driving ongoing research on the pathophysiology of Parkinson's disease (PD). In line with this, alpha-syn is considered to be the guilty protein in the disease process, and it may be targeted through precision medicine to modify disease progression. Therefore, designing specific tools to block the aggregation and spreading of alpha-syn represents a major effort in the development of disease-modifying therapies in PD...
April 1, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38600154/am6527-a-neutral-cb1-receptor-antagonist-suppresses-opioid-taking-and-seeking-as-well-as-cocaine-seeking-in-rodents-without-aversive-effects
#4
JOURNAL ARTICLE
Omar Soler-Cedeño, Hannah Alton, Guo-Hua Bi, Emily Linz, Lipin Ji, Alexandros Makriyannis, Zheng-Xiong Xi
Preclinical research has demonstrated the efficacy of CB1 receptor (CB1R) antagonists in reducing drug-taking behavior. However, clinical trials with rimonabant, a CB1R antagonist with inverse agonist profile, failed due to severe adverse effects, such as depression and suicidality. As a result, efforts have shifted towards developing novel neutral CB1R antagonists without an inverse agonist profile for treating substance use disorders. Here, we assessed AM6527, a CB1R neutral antagonist, in addiction animal models...
April 10, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38555114/current-treatments-of-alcohol-use-disorder
#5
JOURNAL ARTICLE
Tommaso Dionisi, Giovanna Di Sario, Lorenzo De Mori, Giorgia Spagnolo, Mariangela Antonelli, Claudia Tarli, Luisa Sestito, Francesco Antonio Mancarella, Daniele Ferrarese, Antonio Mirijello, Gabriele Angelo Vassallo, Antonio Gasbarrini, Giovanni Addolorato
Emerging treatments for alcohol dependence reveal an intricate interplay of neurobiological, psychological, and circumstantial factors that contribute to Alcohol Use Disorder (AUD). The approved strategies balancing these factors involve extensive manipulations of neurotransmitter systems such as GABA, Glutamate, Dopamine, Serotonin, and Acetylcholine. Innovative developments are engaging mechanisms such as GABA reuptake inhibition and allosteric modulation. Closer scrutiny is placed on the role of Glutamate in chronic alcohol consumption, with treatments like NMDA receptor antagonists and antiglutamatergic medications showing significant promise...
2024: International Review of Neurobiology
https://read.qxmd.com/read/38537670/muscarinic-receptor-activators-as-novel-treatments-for-schizophrenia
#6
REVIEW
Steven M Paul, Samantha E Yohn, Stephen K Brannan, Nichole M Neugebauer, Alan Breier
Achieving optimal treatment outcomes for individuals living with schizophrenia remains challenging, despite 70 years of drug development efforts. Many chemically distinct antipsychotics have been developed over the past seven decades with improved safety and tolerability but with only slight variation in efficacy. All currently prescribed antipsychotics act as antagonists or partial agonists at the dopamine D2 receptor. With only a few possible exceptions, antipsychotic drugs have similar and modest efficacy for treating positive symptoms and are relatively ineffective in addressing the negative and cognitive symptoms of the disease...
March 25, 2024: Biological Psychiatry
https://read.qxmd.com/read/38514654/nucleus-accumbens-d1-and-d2-expressing-neurons-control-the-balance-between-feeding-and-activity-mediated-energy-expenditure
#7
JOURNAL ARTICLE
Roman Walle, Anna Petitbon, Giulia R Fois, Christophe Varin, Enrica Montalban, Lola Hardt, Andrea Contini, Maria Florencia Angelo, Mylène Potier, Rodrigue Ortole, Asma Oummadi, Véronique De Smedt-Peyrusse, Roger A Adan, Bruno Giros, Francis Chaouloff, Guillaume Ferreira, Alban de Kerchove d'Exaerde, Fabien Ducrocq, François Georges, Pierre Trifilieff
Accumulating evidence points to dysregulations of the Nucleus Accumbens (NAc) in eating disorders (ED), however its precise contribution to ED symptomatic dimensions remains unclear. Using chemogenetic manipulations in male mice, we found that activity of dopamine D1 receptor-expressing neurons of the NAc core subregion facilitated effort for a food reward as well as voluntary exercise, but decreased food intake, while D2-expressing neurons have opposite effects. These effects are congruent with D2-neurons being more active than D1-neurons during feeding while it is the opposite during running...
March 21, 2024: Nature Communications
https://read.qxmd.com/read/38476136/invasive-ant-learning-is-not-affected-by-seven-potential-neuroactive-chemicals
#8
JOURNAL ARTICLE
Henrique Galante, Tomer J Czaczkes
Argentine ants Linepithema humile are one of the most damaging invasive alien species worldwide. Enhancing or disrupting cognitive abilities, such as learning, has the potential to improve management efforts, for example by increasing preference for a bait, or improving ants' ability to learn its characteristics or location. Nectar-feeding insects are often the victims of psychoactive manipulation, with plants lacing their nectar with secondary metabolites such as alkaloids and non-protein amino acids which often alter learning, foraging, or recruitment...
February 2024: Current Zoology
https://read.qxmd.com/read/38457390/now-it-s-your-turn-eye-blink-rate-in-a-jenga-task-modulated-by-interaction-of-task-wait-times-effortful-control-and-internalizing-behaviors
#9
JOURNAL ARTICLE
Kelley E Gunther, Xiaoxue Fu, Leigha A MacNeill, Morgan Jones, Briana Ermanni, Koraly Pérez-Edgar
Dopamine is a versatile neurotransmitter with implications in many domains, including anxiety and effortful control. Where high levels of effortful control are often regarded as adaptive, other work suggests that high levels of effortful control may be a risk factor for anxiety. Dopamine signaling may be key in understanding these relations. Eye blink rate is a non-invasive proxy metric of midbrain dopamine activity. However, much work with eye blink rate has been constrained to screen-based tasks which lack in ecological validity...
2024: PloS One
https://read.qxmd.com/read/38429498/potential-therapeutics-for-effort-related-motivational-dysfunction-assessing-novel-atypical-dopamine-transport-inhibitors
#10
JOURNAL ARTICLE
Alev Ecevitoglu, Nicolette Meka, Renee A Rotolo, Gayle A Edelstein, Sonya Srinath, Kathryn R Beard, Carla Carratala-Ros, Rose E Presby, Jianjing Cao, Amarachi Okorom, Amy H Newman, Mercè Correa, John D Salamone
People with depression and other neuropsychiatric disorders can experience motivational dysfunctions such as fatigue and anergia, which involve reduced exertion of effort in goal-directed activity. To model effort-related motivational dysfunction, effort-based choice tasks can be used, in which rats can select between obtaining a preferred reinforcer by high exertion of effort vs. a low effort/less preferred option. Preclinical data indicate that dopamine transport (DAT) inhibitors can reverse pharmacologically-induced low-effort biases and increase selection of high-effort options in effort-based choice tasks...
March 1, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38422996/dopamine-polymerization-mediated-surface-functionalization-toward-advanced-bacterial-therapeutics
#11
JOURNAL ARTICLE
Lu Wang, Jinyao Liu
ConspectusBacteria-based therapy has spotlighted an unprecedented potential in treating a range of diseases, given that bacteria can be used as both drug vehicles and therapeutic agents. However, the use of bacteria for disease treatment often suffers from unsatisfactory outcomes, due largely to their suboptimal bioavailability, dose-dependent toxicity, and low targeting colonization. In the past few years, substantial efforts have been devoted to tackling these difficulties, among which methods capable of integrating bacteria with multiple functions have been extensively pursued...
February 29, 2024: Accounts of Chemical Research
https://read.qxmd.com/read/38412825/neuroscience-therapy-modulates-decision-making-in-parkinson-s-disease
#12
JOURNAL ARTICLE
Damian M Herz
There is mounting evidence that decision-making can be affected by treatment in Parkinson's disease. A new study shows that dopamine and deep brain stimulation, two mainstay treatments of Parkinson's, differently affect how patients make decisions weighing rewards against effort costs.
February 26, 2024: Current Biology: CB
https://read.qxmd.com/read/38409080/selective-alterations-of-endocannabinoid-system-genes-expression-in-obsessive-compulsive-disorder
#13
JOURNAL ARTICLE
Fabio Bellia, Antonio Girella, Eugenia Annunzi, Beatrice Benatti, Matteo Vismara, Alberto Priori, Fabiana Festucci, Federico Fanti, Dario Compagnone, Walter Adriani, Bernardo Dell'Osso, Claudio D'Addario
Obsessive Compulsive Disorder (OCD) is listed as one of the top 10 most disabling neuropsychiatric conditions in the world. The neurobiology of OCD has not been completely understood and efforts are needed in order to develop new treatments. Beside the classical neurotransmitter systems and signalling pathways implicated in OCD, the possible involvement of the endocannabinoid system (ECS) has emerged in pathophysiology of OCD. We report here selective downregulation of the genes coding for enzymes allowing the synthesis of the endocannabinoids...
February 26, 2024: Translational Psychiatry
https://read.qxmd.com/read/38396375/blocking-the-self-destruct-program-of-dopamine-neurons-through-macrophage-migration-inhibitory-factor-nuclease-inhibition
#14
JOURNAL ARTICLE
Jaimin Patel, Valina L Dawson, Ted M Dawson
Parkinson's disease (PD) is a progressive neurodegenerative condition that pathognomonically involves the death of dopaminergic neurons in the substantia nigra pars compacta, resulting in a myriad of motor and non-motor symptoms. Given the insurmountable burden of this disease on the population and healthcare system, significant efforts have been put forth toward generating disease modifying therapies. This class of treatments characteristically alters disease course, as opposed to current strategies that focus on managing symptoms...
February 23, 2024: Movement Disorders: Official Journal of the Movement Disorder Society
https://read.qxmd.com/read/38353846/a-new-perspective-on-positive-symptoms-expression-of-damage-or-self-defence-mechanism-of-the-brain
#15
JOURNAL ARTICLE
Annibale Antonioni, Emanuela Maria Raho, Mariachiara Sensi, Francesco Di Lorenzo, Luciano Fadiga, Giacomo Koch
Usually, positive neurological symptoms are considered as the consequence of a mere, afinalistic and abnormal increase in function of specific brain areas. However, according to the Theory of Active Inference, which argues that action and perception constitute a loop that updates expectations according to a Bayesian model, the brain is rather an explorer that formulates hypotheses and tests them to assess the correspondence between internal models and reality. Moreover, the cerebral cortex is characterised by a continuous "conflict" between different brain areas, which constantly attempt to expand in order to acquire more of the limited available computational resources, by means of their dopamine-induced neuroplasticity...
February 14, 2024: Neurological Sciences
https://read.qxmd.com/read/38351379/free-will-an-example-of-the-dopaminergic-system
#16
JOURNAL ARTICLE
Natalia Ivlieva
Neuroscience has convinced people that much of their behavior is determined by causes unknown to them and beyond their control. However, are advances in neuroscience truly a prerequisite for such beliefs? Robert Kane's theory of ultimate responsibility is libertarian theory. Its innovative nature makes it possible to discuss the neurophysiological basis of its postulates. Using the functions of the midbrain dopaminergic system as an example, this article provides an overview of this neurophysiological basis...
February 14, 2024: Integrative Psychological & Behavioral Science
https://read.qxmd.com/read/38334518/directed-evolution-of-near-infrared-serotonin-nanosensors-with-machine-learning-based-screening
#17
JOURNAL ARTICLE
Seonghyeon An, Yeongjoo Suh, Payam Kelich, Dakyeon Lee, Lela Vukovic, Sanghwa Jeong
In this study, we employed a novel approach to improve the serotonin-responsive ssDNA-wrapped single-walled carbon nanotube (ssDNA-SWCNT) nanosensors, combining directed evolution and machine learning-based prediction. Our iterative optimization process is aimed at the sensitivity and selectivity of ssDNA-SWCNT nanosensors. In the three rounds for higher serotonin sensitivity, we substantially improved sensitivity, achieving a remarkable 2.5-fold enhancement in fluorescence response compared to the original sequence...
January 23, 2024: Nanomaterials
https://read.qxmd.com/read/38329794/neoteric-semiembedded-%C3%AE-tricalcium-phosphate-promotes-osteogenic-differentiation-of-mesenchymal-stem-cells-under-cyclic-stretch
#18
JOURNAL ARTICLE
Yujie Dai, Qingyun Xie, Yimeng Zhang, Yiwan Sun, Shaomei Zhu, Chongyu Wang, Youhua Tan, Xue Gou
β-Tricalcium phosphate (β-TCP) is a bioactive material for bone regeneration, but its brittleness limits its use as a standalone scaffold. Therefore, continuous efforts are necessary to effectively integrate β-TCP into polymers, facilitating a sturdy ion exchange for cell regulation. Herein, a novel semiembedded technique was utilized to anchor β-TCP nanoparticles onto the surface of the elastic polymer, followed by hydrophilic modification with the polymerization of dopamine. Cell adhesion and osteogenic differentiation of mesenchymal stem cells (MSCs) under static and dynamic uniaxial cyclic stretching conditions were investigated...
February 8, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38272669/novel-benzofuran-derivatives-induce-monoamine-release-and-substitute-for-the-discriminative-stimulus-effects-of-3-4-methylenedioxymethamphetamine
#19
JOURNAL ARTICLE
Candace B Johnson, Donna Walther, Matthew J Baggott, Lisa E Baker, Michael H Baumann
3,4-Methylenedioxymethamphetamine (MDMA) has shown efficacy as a medication adjunct for treating post-traumatic stress disorder (PTSD). However, MDMA is also used in non-medical contexts that pose risk for cardiovascular and neurological complications. It is well established that MDMA exerts its effects by stimulating transporter-mediated release of the monoamines, 5‑hydroxytryptamine (5-HT), norepinephrine, and dopamine. Current research efforts are aimed at developing MDMA-like monoamine releasers with better efficacy and safety profiles...
January 25, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/38242133/separate-gut-brain-circuits-for-fat-and-sugar-reinforcement-combine-to-promote-overeating
#20
JOURNAL ARTICLE
Molly McDougle, Alan de Araujo, Arashdeep Singh, Mingxin Yang, Isadora Braga, Vincent Paille, Rebeca Mendez-Hernandez, Macarena Vergara, Lauren N Woodie, Abhishek Gour, Abhisheak Sharma, Nikhil Urs, Brandon Warren, Guillaume de Lartigue
Food is a powerful natural reinforcer that guides feeding decisions. The vagus nerve conveys internal sensory information from the gut to the brain about nutritional value; however, the cellular and molecular basis of macronutrient-specific reward circuits is poorly understood. Here, we monitor in vivo calcium dynamics to provide direct evidence of independent vagal sensing pathways for the detection of dietary fats and sugars. Using activity-dependent genetic capture of vagal neurons activated in response to gut infusions of nutrients, we demonstrate the existence of separate gut-brain circuits for fat and sugar sensing that are necessary and sufficient for nutrient-specific reinforcement...
January 5, 2024: Cell Metabolism
keyword
keyword
94958
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.